Literature DB >> 29626219

Smoking and the intestinal microbiome.

Ziv Savin1, Shaye Kivity1,2,3,4, Hagith Yonath1,5, Shoenfeld Yehuda6,7,8.   

Abstract

Studies are emerging alluding to the role of intestinal microbiome in the pathogenesis of diseases. Intestinal microbiome is susceptible to the influence of environmental factors such as smoking, and recent studies have indicated microbiome alterations in smokers. The aim of the study was to review the literature regarding the impact of smoking on the intestinal microbiome. A literature review of publications in PUBMED was performed using combinations of the terms "Intestinal/Gut/Gastrointestinal/Colonic" with "Microbiome/Microbiota/Microbial/Flora" and "Smoking/Smoker/Tobacco". We selected studies that were published between the years 2000 and 2016 as our inclusion criteria. Observational and interventional studies suggest that the composition of intestinal microbiome is altered due to smoking. In these studies, Proteobacteria and Bacteroidetes phyla were increased, as well as the genera of Clostridium, Bacteroides and Prevotella. On the other hand, Actinobacteria and Firmicutes phyla as well as the genera Bifidobacteria and Lactococcus were decreased. Smoking also decreased the diversity of the intestinal microbiome. Mechanisms that have been suggested to explain the effect of smoking on intestinal microbiome include: oxidative stress enhancement, alterations of intestinal tight junctions and intestinal mucin composition, and changes in acid-base balance. Interestingly, some smoking-induced alterations of intestinal microbiome resemble those demonstrated in conditions such as inflammatory bowel disease and obesity. Further studies should be performed to investigate this connection. Smoking has an effect on intestinal microbiome and is suggested to alter its composition. This interaction may contribute to the development of intestinal and systemic diseases, particularly inflammatory bowel diseases.

Entities:  

Keywords:  Autoimmunity; Dysbiosis; Inflammatory bowel disease; Intestinal microbiome; Smoking

Mesh:

Year:  2018        PMID: 29626219     DOI: 10.1007/s00203-018-1506-2

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  54 in total

Review 1.  Gastrointestinal tract microbiota modifications in systemic sclerosis.

Authors:  Elizabeth R Volkmann; Anna-Maria Hoffmann-Vold
Journal:  Eur J Rheumatol       Date:  2019-12-19

Review 2.  Impact of maternal smoking on the infant gut microbiota and its association with child overweight: a scoping review.

Authors:  Cara McLean; Shelly Jun; Anita Kozyrskyj
Journal:  World J Pediatr       Date:  2019-07-09       Impact factor: 2.764

3.  Dynamic changes in gut microbiota under the influence of smoking and TNF-α-blocker in patients with ankylosing spondylitis.

Authors:  Fangze Zhang; Cuili Ma; Bin Zhang; Liqi Bi
Journal:  Clin Rheumatol       Date:  2020-03-26       Impact factor: 2.980

4.  Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis.

Authors:  Brett R Loman; Chandra L Shrestha; Rohan Thompson; Judith A Groner; Asuncion Mejias; Kathryn L Ruoff; George A O'Toole; Michael T Bailey; Benjamin T Kopp
Journal:  Pediatr Pulmonol       Date:  2020-04-10

Review 5.  The phenolic interactome and gut microbiota: opportunities and challenges in developing applications for schizophrenia and autism.

Authors:  George E Jaskiw; Mark E Obrenovich; Curtis J Donskey
Journal:  Psychopharmacology (Berl)       Date:  2019-06-13       Impact factor: 4.530

Review 6.  COPD and the gut-lung axis: the therapeutic potential of fibre.

Authors:  Annalicia Vaughan; Zoe A Frazer; Philip M Hansbro; Ian A Yang
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

7.  Tobacco Smoking and the Fecal Microbiome in a Large, Multi-ethnic Cohort.

Authors:  Ajay Prakash; Brandilyn A Peters; Emilia Cobbs; Dia Beggs; Heesun Choi; Huilin Li; Richard B Hayes; Jiyoung Ahn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-05-21       Impact factor: 4.254

8.  Microbiome and Graves' Orbitopathy.

Authors:  Giulia Masetti; Marian Ludgate
Journal:  Eur Thyroid J       Date:  2020-11-05

Review 9.  Microbiology of the American Smokeless Tobacco.

Authors:  A J Rivera; R E Tyx
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-10       Impact factor: 4.813

Review 10.  Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.

Authors:  Gerhard Rogler; Abha Singh; Arthur Kavanaugh; David T Rubin
Journal:  Gastroenterology       Date:  2021-08-03       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.